A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio
Published: 17 February 2021
Likes: 18
Overview
This webinar, at 5pm CET / 4pm GMT, will bring together an internationally-respected faculty to review the PASCAL platform focusing on the recently CE mark approved PASCAL Ace implant system for the treatment of mitral and tricuspid regurgitation.
Through a combination of case presentations, discussion, and a live case procedure from Heidelberg University Hospital, the theory- and practical-based agenda has been formulated to best support everyday practice and enhance patient outcomes.
Pipeline products for tricuspid transcatheter replacement from Edwards Lifesciences will be shown and briefly discussed.
LEARNING OBJECTIVES
- To show latest evidence on what is new in mitral and/or tricuspid valve disease
- Appreciate the clinical impact of the PASCAL platform for MR and TR treatment
- To participate in a step-by-step LIVE demonstration of percutaneous tricuspid leaflet repair with PASCAL Ace implant system
- Discover the potential of transcatheter replacement technologies for the treatment of TR
AUDIENCE
- Interventional Cardiologists
- General Cardiologists
- Heart Failure Specialists
- Echocardiographers
- Nurses
Agenda
Faculty
Downloads
